SKYLINEDX
DEAD

Serial Number

79185230

Owner

SKYLINEDX, B.V.

Filing Date

Oct 22, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SKYLINEDX Trademark

Serial Number: 79185230

SKYLINEDX is a trademark filed by SKYLINEDX, B.V. on October 22, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SKYLINEDX, B.V. (6 trademarks)

ROTTERDAM SCIENCE TOWER
AK ROTTERDAM 3029 , NL

Entity Type: 26

Trademark Details

Filing Date

October 22, 2015

Registration Date

Not Registered

Goods & Services

Software; software and algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the (complex) genetic properties of the patient sample; software for interpreting the obtained raw genetic information for inter alia laboratory users, molecular biologists, pathologists, physicians and patients, comprehensive and relevant information (such as the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of the disease or clinical consequence thereof as well as poor or good prognosis, whether or not in combination with a specific treatment); validated software for secure IT infrastructures for clinical purposes; databases containing anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples

Molecular diagnostic test reagents; molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer; molecular diagnostic test reagents, inter alia on the basis of microarray technology (next generation) sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile, reagents for use in medical genetic testing for the measurement of gene aberrations and mutations, clinical multiplex (research) testing, inter alia, for the determination of the genetic sub-type of a patient; prognostic test reagents; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; reagents and other supplies for diagnostic testing; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells

Compilation of medical and veterinary information

Medical analysis services; analysis of medical and veterinary test scores and data for others; medical and veterinary information services provided via the internet

Scientific research for the benefit of the development of molecular diagnostic tests; developing software for performing diagnostic tests for medical purposes, as well as developing software and algorithms and / or databases for translation (reading), analyzing and interpreting test results; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers, testing, and (corresponding) methods of treatment; leasing of computer software for reading test results; development and testing services for the certification of quality or standards of (molecular) diagnostic tests

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 6, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 24, 2017 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 9, 2017 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 9, 2017 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 15, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 30, 2017 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 10, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 9, 2016 ABN2
REFUSAL PROCESSED BY IB
May 14, 2016 RFNT
APPLICATION FILING RECEIPT MAILED
Apr 1, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 29, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2016 REPR